AzTrials
AzTrials

EdentulousNCT02867982

Platform Switched Implant and Bone Level Alteration

A study testing Subcrestal implant placement, Paracrestal implant placement and prophylactic antibiotics in people with Edentulous and Bone Resorption, run by Beijing University Health Science Center.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a two-year prospective randomized clinical study to to evaluate whether the gingival thickness and insertion depth of dental implants have any influence on marginal bone levels changes around platform switched implants. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Edentulous, Bone Resorption
What is being tested?
Subcrestal implant placement, Paracrestal implant placement and prophylactic antibiotics
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
No sites listed yet
Study dates
Jul 2016to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • lose of two posterior teeth more than 3 months
  • generally healthy (ASA score I)
  • non-smoking
  • periodontally healthy
  • sufficient bone volume to place an implant without augmentation procedure

Who cannot join

  • medical and/or psychiatric contraindication to dental implant restoration
  • local infection
  • pregnancy or lactating
  • poor oral hygiene
  • tissue deficiency

About this study

Official title: Influence of Soft Tissue Thickness and Insertion Depth of Platform Switched Implants on Crestal Bone Level Alteration

This is a two-year prospective randomized clinical study to to evaluate whether the gingival thickness and insertion depth of dental implants have any influence on marginal bone levels changes around platform switched implants.

Read the detailed description

Patient selection: Patients at the Department of Oral Implantology, Peking University School and Hospital of stomatology, Bei Jing, China, who seek for implant restoration for two continous posterior teeth are potentially recruited. Inclusion criteria are generally healthy (ASA score I), non-smoking, periodontally healthy, and sufficient bone volume to place an implant without augmentation procedure. Patients were excluded in cases of medical and/or psychiatric contraindications, local infection, pregnancy or lactating, poor oral hygiene, tissue deficiency, or not willing to participate in this study.

Randomization: The two implant sites of each subject are randomly assigned to two different group with a predefined randomization tables. In order to reduce the chance of unfavorable splits between groups in terms of key prognostic factors,the randomization process will take into account the following variables: patient's gender, age, presence of adjacent teeth, distal extension sites and site location in the dental arch. Assignment will perform using a sealed envelope.

Surgical protocol: Before the surgical procedure, prophylactic antibiotics of 1g amoxicillin will prescribed to the patient 1 h before surgery, and continued with 2 g/day for 6 days. After crestal incision, full thickness buccal flap was raised, whereas lingual part was not elevated. Thickness of soft tissues was measured with 1.0-mm marked periodontal probe on the top of bone crest in the center of the two future implant sites. This ensured direct visibility of mucosal thickness during measurement. After measurements, full-thickness lingual flap is raised and subsequent implant osteotomy is finished, Two dental implants (Dentsply Implants Manufacturing GmbH, Mannheim, Germany) with diameter of 3.5 mm are ready to torch into the bone cavities. In one site (group 1), the platform of implants are placed at the crestal level (flush to the alveolar ridge) . In the other site (group 2), the implants are placed 1mm below the alveolar ridge. narrow healing abutment are connected to all the implants. The flap are repositioned and closed with interrupted single sutures. Implants are allowed for a un-submerged healing. 3 month after healing, the implant level impressions are taken, splinted restorations of two neighbouring posterior teeth are delivered 2 weeks later.

Radiographic and Clinical Examination: All the patients are required for recall visit at 3, 6,12 months and 2 years post surgery. A digital peri-apical radiograph was taken at the 1 year and 2year follow-up examination for bone level evaluation using a film holder to aim the x-ray beam perpendicular to the implant threads, and the implant length is used as calibration for the measurement. Using a image analysis software (ImageJ, version 1.47, NIH, Bethesda, MD, USA), the investigators are able to have an accurate assessment of the crest of bone and to analyze the bone changes over period of time. Bone loss was defined as a positive value and bone gain as a negative one. Mean values, standard deviations, and maximum and minimum values were calculated. Furthermore, periodontal parameters [bleeding on probing (BOP), probing pocket depth (PPD), modified plaque index on adjacent teeth and implants] were assessed.

Being tested
Subcrestal implant placement, Paracrestal implant placement, prophylactic antibiotics, dental implant, x-ray examination
Keywords
platform switching, crestal bone remodeling, soft tissue thickness, dental implant
Medical subject headings
Mouth, Edentulous, Bone Resorption

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Subcrestal implant placementProcedure or surgery

    Dental implants placed 2 mm below the alveolar ridge

  • Paracrestal implant placementProcedure or surgery

    Dental implants placed flush to the alveolar ridge

  • prophylactic antibioticsDrug

    amoxicillin was used before and after implant surgery for prophylactic reasons

  • dental implantDevice

    dental implants (Ankylos® system,Dentsply Implants Manufacturing GmbH, Mannheim, Germany) were surgically placed into the edentulous alveolar ridge

  • x-ray examinationRadiation

    radiographies were taken before treatment and at different time point during the follow-up period

Study groups in NCT02867982
Study groupRoleWhat they receive
SubcrestalOtherimplants that are placed below the alveolar ridge
Receives: Procedure: Subcrestal implant placement; Drug: prophylactic antibiotics; Device: dental implant; Radiation: x-ray examination
ParacrestalOtherimplants that are placed flush to the alveolar ridge
Receives: Procedure: Paracrestal implant placement; Drug: prophylactic antibiotics; Device: dental implant; Radiation: x-ray examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes of marginal bone levels of dental implant

    Mesial and distal marginal bone level alterations at different time point compared with the base line. Marginal bone levels were measured with an image analysis software to the accuracy of 0.01 mm and the implant length is used as calibration for the measurement.

    Measured: 3 months, 6 months, 1 year and 2 years post intervention (implant surgery)

Secondary outcomes (3)
  1. Bleeding on probing(BOP)

    bleeding index whiling probing the implant restorations

    Measured: 3 months, 6 months, 1 year and 2 years post intervention (implant surgery)

  2. Probing pocket depth(PPD)

    probing depth of implant supported restorations

    Measured: 3 months, 6 months, 1 year and 2 years post intervention (implant surgery)

  3. modified plaque index(PI)

    Modified plaque index to evaluate the oral hygiene conditions

    Measured: 3 months, 6 months, 1 year and 2 years post intervention (implant surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionDec 2019 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02867982
Sponsor's protocol ID
I-AN-16-002
Status last verified
Aug 2016
First submitted
24 Jul 2016
Last updated
16 Aug 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Subcrestal implant placement, Paracrestal implant placement and prophylactic antibiotics in people with Edentulous and Bone Resorption, run by Beijing University Health Science Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes of marginal bone levels of dental implant (time frame: 3 months, 6 months, 1 year and 2 years post intervention (implant surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in